Rigalli J, Gagliardi A, Diester K, Bajraktari-Sylejmani G, Blank A, Burhenne J
Int J Mol Sci. 2024; 25(7).
PMID: 38612927
PMC: 11012658.
DOI: 10.3390/ijms25074118.
Salama B, El-Sherbini E, El-Sayed G, El-Adl M, Kanehira K, Taniguchi A
Int J Mol Sci. 2020; 21(2).
PMID: 31963452
PMC: 7013663.
DOI: 10.3390/ijms21020605.
Hennenberg E, Eyking A, Reis H, Cario E
PLoS One. 2017; 12(7):e0180834.
PMID: 28686677
PMC: 5501609.
DOI: 10.1371/journal.pone.0180834.
Li T, Kong A, Ma Z, Liu H, Liu P, Xiao Y
Oncotarget. 2016; 7(15):20236-48.
PMID: 26934120
PMC: 4991450.
DOI: 10.18632/oncotarget.7752.
Hartz A, Zhong Y, Wolf A, LeVine 3rd H, Miller D, Bauer B
J Neurosci. 2016; 36(6):1930-41.
PMID: 26865616
PMC: 4748076.
DOI: 10.1523/JNEUROSCI.0350-15.2016.
CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination.
Ravindranath A, Kaur S, Wernyj R, Kumaran M, Miletti-Gonzalez K, Chan R
Oncotarget. 2015; 6(28):26308-21.
PMID: 26299618
PMC: 4694903.
DOI: 10.18632/oncotarget.4763.
Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.
Nourbakhsh M, Jaafari M, Lage H, Abnous K, Mosaffa F, Badiee A
Iran J Basic Med Sci. 2015; 18(4):385-92.
PMID: 26019802
PMC: 4439454.
The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.
Akkaya B, Zolnerciks J, Ritchie T, Bauer B, Hartz A, Sullivan J
Mol Membr Biol. 2015; 32(2):39-45.
PMID: 26006083
PMC: 4844833.
DOI: 10.3109/09687688.2015.1023378.
Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?.
Callaghan R, Luk F, Bebawy M
Drug Metab Dispos. 2014; 42(4):623-31.
PMID: 24492893
PMC: 3965902.
DOI: 10.1124/dmd.113.056176.
Where is it and How Does it Get There - Intracellular Localization and Traffic of P-glycoprotein.
Fu D
Front Oncol. 2014; 3:321.
PMID: 24416721
PMC: 3874554.
DOI: 10.3389/fonc.2013.00321.
Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells.
Lee S, Osei-Twum J, Wasan K
Mol Pharm. 2013; 10(6):2323-30.
PMID: 23611024
PMC: 3674641.
DOI: 10.1021/mp300668e.
Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach.
Malmo J, Sandvig A, Varum K, Strand S
PLoS One. 2013; 8(1):e54182.
PMID: 23372682
PMC: 3553124.
DOI: 10.1371/journal.pone.0054182.
P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.
McCaffrey G, Staatz W, Sanchez-Covarrubias L, Finch J, DeMarco K, Laracuente M
J Neurochem. 2012; 122(5):962-75.
PMID: 22716933
PMC: 3851298.
DOI: 10.1111/j.1471-4159.2012.07831.x.
FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.
Joyner D, Trang S, Aboulafia A, Damron T, Randall R, Randall R
Fam Cancer. 2009; 8(4):569-80.
PMID: 19728161
DOI: 10.1007/s10689-009-9288-y.
Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells.
Marquez B, Caceres N, Mingeot-Leclercq M, Tulkens P, Van Bambeke F
Antimicrob Agents Chemother. 2009; 53(6):2410-6.
PMID: 19307362
PMC: 2687251.
DOI: 10.1128/AAC.01428-08.
Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.
Yue W, Abe K, Brouwer K
Mol Pharm. 2008; 6(1):134-43.
PMID: 19105722
PMC: 3135650.
DOI: 10.1021/mp800100e.
Psorospermin structural requirements for P-glycoprotein resistance reversal.
Carey S, Gleason-Guzman M, Gokhale V, Hurley L
Mol Cancer Ther. 2008; 7(11):3617-23.
PMID: 19001443
PMC: 2586895.
DOI: 10.1158/1535-7163.MCT-08-0519.
Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.
Jin W, Scotto K, Hait W, Yang J
Biochem Pharmacol. 2007; 74(6):851-9.
PMID: 17662696
PMC: 1987360.
DOI: 10.1016/j.bcp.2007.06.017.
Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
Chen X, Wang Q, Guan J, Huang Z, Zhang W, Zhang B
World J Gastroenterol. 2006; 12(21):3332-7.
PMID: 16733848
PMC: 4087887.
DOI: 10.3748/wjg.v12.i21.3332.